The impact of assumptions regarding vaccine-induced immunity on the public health and cost-effectiveness of hepatitis A vaccination: Is one dose sufficient?

References

• World Health Organization. WHO position paper on hepatitis vaccines. Weekly epidemiological record 2012; 87:261-76; PMID:22905367
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. Summary of notifiable diseases. MMWR Morb Mortal Wkly Rep 2001; 48:89-98.
   Google Scholar
• Siegriest CA (2008) Vaccine Immunology. Vaccines. Oxford, U.K.: Elsevier. pp 17-36.
   Google Scholar
• Van Damme P, Banatvala J, Fay O, Iwarson S, McMahon B, Van Herck K, Shouval D, Bonanni P, Connor B, Cooksley G et al. Hepatitis A booster vaccination: is there a need? Lancet 2003; 362:1065-71; PMID:14522539; http://dx.doi.org/10.1016/S0140-6736(03)14418-2
   PubMed Web of Science ®Google Scholar
• Van Damme P, Van Herck K. Hepatitis A vaccination: more convenience for the traveller? Proceedings of the 3rd European Conference on Travel Medicine; 2002 May 15–18; Florence, Italy. Rimini: World Health Organization Collaborating Centre for Travel Medicine, 2002; 50 ( abstr 31).
   Google Scholar
• Iwarson S, Lindh M, Widerstrom L. Excellent booster response 4-8 y after a single primary dose of an inactivated hepatitis A vaccine. J Travel Med 2004; 11:120-1; PMID:15109480; http://dx.doi.org/10.2310/7060.2004.17079
   PubMed Web of Science ®Google Scholar
• Landry P, Tremblay S, Darioli R, Genton B. Inactivated hepatitis A vaccine booster given >/=24 months after the primary dose. Vaccine 2000; 19: 399-402; PMID:11027799; http://dx.doi.org/10.1016/S0264-410X(00)00188-2
   PubMed Web of Science ®Google Scholar
• Ministerio de Salud y Ambiente, Argentina. Resolución 653/05, 113(30677). Buenos Aires, Argentina: Boletín Oficial de la República Argentina; 2005. p. 3. Available at: www1.hcdn.gov.ar/BO/boletin05/2005–06/BO17-06-2005leg.pdf. Accessed July 5, 2013.
   Google Scholar
• Ott JJ, Wiersma ST. Single-dose administration of inactivated hepatitis A vaccination in the context of hepatitis A vaccine recommendations. Int J Infect Dis 2013; (11):e939-44; PMID:23791857; http://dx.doi.org/10.1016/j.ijid.2013.04.012
   PubMedGoogle Scholar
• Hatz C, van der Ploeg R, Beck BR, Frösner G, Hunt M, Herzog C. Successful memory response following a booster dose with a virosome-formulated hepatitis A vaccine delayed up to 11 years. Clin Vaccine Immunol 2011; 18:pp. 885-887; PMID:21411599
   PubMed Web of Science ®Google Scholar
• Cervio G, Trentadue J, D'Agostino D, Luque C, Giorgi M, Armoni J, Debbag R. Decline in HAV-associated fulminant hepatic failure and liver transplant in children in Argentina after the introduction of a universal hepatitis A vaccination program. Hepat Med 2011; 3:99-106; PMID:24367225; http://dx.doi.org/10.2147/HMER.S22309
   PubMedGoogle Scholar
• Vizzotti C, González J, Gentile A, Rearte A, Ramonet M, Cañero-Velasco MC, Pérez Carrega ME, Urueña A, Diosque M. Impact of the single-dose immunization strategy against hepatitis A in Argentina.Pediatr Infect Dis J 2014 Jan; 33(1):84-8; http://dx.doi.org/10.1097/INF.0000000000000042
   PubMed Web of Science ®Google Scholar
• Van Herck K, Crasta PD, Messier M, Hardt K, Van Damme P. Seventeen year antibody persistence in adults primed with two doses of an inactivated hepatitis A vaccine. Hum Vaccin Immunother 2012; 8(3):323-27; PMID:22327499; http://dx.doi.org/10.4161/hv.18617
   PubMed Web of Science ®Google Scholar
• Hens N, Habteab Ghebretinsae A, Hardt K, Van Damme P, Van Herck K. Model based estimates of long-term persistence of inactivated hepatitis A vaccine-induced antibodies in adults. Vaccine 2014; 32(13):1507-13; PMID:24508042; http://dx.doi.org/10.1016/j.vaccine.2013.10.088
   PubMed Web of Science ®Google Scholar
• Ott JJ, Irving G, Wiersma ST. Long-term protective effects of hepatitis A vaccines. A systematic review.Vaccine 2012; 31(1):3-11; PMID:22609026; http://dx.doi.org/10.1016/j.vaccine.2012.04.104
   PubMed Web of Science ®Google Scholar
• Van Der Meeren O, Crasta P, de Ridder M. A retrospective pooled analysis assessing the effect of age on the immunogenicity of Havrix™ in healthy adults. Hum Vaccin Immunother 2015; 11(7):1729-34; PMID:26029816; http://dx.doi.org/10.1080/21645515.2015.1045167
   PubMed Web of Science ®Google Scholar
• Murphy TV, Stephen M, Bell BP. Hepatitis A vaccines Vaccines. In: Plotkin SA, Orenstein WA, Offit PA (eds) (6th edition): Elsevier Saunders; 2013.
   Google Scholar
• Lazcano-Ponce E, Conde-Gonzalez C, Rojas R et al. Seroprevalence of hepatitis A virus in a cross-sectional study in Mexico Implications for hepatitis A vaccination. Hum Vaccin Immunother 2013; 9(2): 375-81; PMID:23291940; http://dx.doi.org/10.4161/hv.22774
   PubMed Web of Science ®Google Scholar
• Carlos F, Gomez JA, Anaya P, Romano-Mazzotti L. Health economic assessment of universal immunization of toddlers against Hepatitis A virus (HAV) in Mexico. Hum Vaccin Immunother 2015; 26:0. [Epub ahead of print]
   Google Scholar
• Suwantika AA, Yegenoglu S, Riewpaiboon A et al. Economic evaluations of hepatitis A vaccination in middle-income countries. Expert Rev Vaccines 2013; 12:1479-1494; PMID:24168129; http://dx.doi.org/10.1586/14760584.2013.851008
   PubMed Web of Science ®Google Scholar
• WHO 2011. The immunological basis for immunization series: module 18: hepatitis A. (Immunological basis for immunization series; module 18). World Health Organization. II.Series. ISBN 978 92 4 150142 2.
   Google Scholar
• Van Herck K, Jacquet JM, Van Damme P. Antibody persistence and immune memory in healthy adults following vaccination with a two-dose inactivated hepatitis A vaccine: long-term follow-up at 15 years. J Med Virol 2011; 83(11):1885-91; PMID:21915861; http://dx.doi.org/10.1002/jmv.22200
   PubMed Web of Science ®Google Scholar
• Melgaço JG, Morgado LN, Santiago MA, Oliveira JM, Lewis-Ximenez LL, Hasselmann B, C-ruz OG, Pinto MA, Vitral CL. A single dose of inactivated hepatitis A vaccine promotes HAV-specific memory cellular response similar to that induced by a natural infection. Vaccine 2015; 33(32):3813-20; http://dx.doi.org/10.1016/j.vaccine.2015.06.099
   PubMed Web of Science ®Google Scholar
• Hens N, Habteab Ghebretinsae A, Hardt K, Van Damme P, Van Herck K. Model based estimates of long-term persistence of inactivated hepatitis A vaccine-induced antibodies in adults. Vaccine 2014; 32(13):1507-13; PMID:24508042; http://dx.doi.org/10.1016/j.vaccine.2013.10.088
   PubMed Web of Science ®Google Scholar
• Van Effelterre T, De Antonio-Suarez R, Cassidy A, Romano-Mazotti L, Marano C. Model-based projections of the population-level impact of hepatitis A vaccination in Mexico. Hum Vaccin Immunother 2012; 8:1099-1108; PMID:22854667; http://dx.doi.org/10.4161/hv.20549
   PubMed Web of Science ®Google Scholar